This open-label field trial evaluates the effects of treatment with a multi-pathway dietary supplement (Stem Cell 100+) that has been commercially available for several years. The objective of the intervention trial is to determine if normal subjects over 35 years of age experience any observable health benefits from the dietary supplement as to their blood pressure, pulse rate, blood cholesterol, lung capacity, stress levels, or self reported changes in markers of overall health and life expectancy.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Blood Pressure
Timeframe: Baseline and at an average of 15 weeks
HDL Cholesterol
Timeframe: Baseline and at an average of 15 weeks
Lung Capacity
Timeframe: Baseline and at an average of 15 weeks
Stress Level
Timeframe: Baseline and at an average of 15 weeks
Heart Rate
Timeframe: Baseline and at an average of 15 weeks